The Leukemia Inhibitory Factor and Its Receptor

https://doi.org/10.1016/S0065-2776(08)60497-6Get rights and content

Publisher Summary

This chapter focuses on the leukemia inhibitory factor (LIF) and its receptor that exemplifies many features of cytokine biology. The gene encoding LIF has been cloned and its product characterized extensively; LIF binds to receptors on responsive cells with high and low affinity and the molecular basis for the two types of receptors are determined. Many protein factors that affect the growth and differentiation of mammalian cells are characterized and are collectively termed growth factors or cytokines. The biochemical rationale for the two forms of LIF, one soluble and the other immobilized, are discussed and the suggestion made that the immobilized LIF may be deposited as a topological or temporal signal in the developing embryo. LIF expression fluctuates in different tissues during development, there being more in adult brain than in embryonic brain and more in day 1 postnatal heart than in adult heart. The development of primordial germ cells is also affected by LIF. A combination of LIF and steel factor improves primordial germ cell survival and proliferative capacity in vitro. There are two clinically interesting systems in which LIF is demonstrated to be active—namely, inflammation and cachexia. Serum LIF levels are elevated in mice treated with bacterial lipopolysaccharide, and LIF is demonstrated to be identical in structure and function to hepatocyte-stimulating factor III that causes the release of acute-phase plasma proteins (APPs).

References (136)

  • I. Godin et al.

    Effects of the steel gene product on mouse primordial germ cells in culture

    Nature (London)

    (1991)
  • J. Heath
  • D.J. Hilton et al.

    Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution

    J. Biol. Chem.

    (1992)
  • D.J. Hilton et al.

    Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines

    J. Biol. Chem.

    (1988)
  • D.J. Hilton et al.

    Purification of a murine leukemia inhibitory factor from Krebs ascites cells

    Anal. Biochem.

    (1988)
  • D.J. Hilton et al.

    Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells

    Proc. Natl. Acad. Sci. U.S.A.

    (1988)
  • Y. Horii et al.

    Involvement of IL-6 in mesangial glomerulonephritis

    J. Immunol.

    (1989)
  • T. Ishibashi et al.

    Interleukin-6 is a potent thrombopoietic factor in vivo in mice

    Blood

    (1989)
  • Y. Ishimi et al.

    IL-6 is produced by osteoblasts and induces bone resorption

    J. Immunol.

    (1990)
  • T. Kitamura et al.

    Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors

    Cell (Cambridge, Mass.)

    (1991)
  • I. Kola et al.

    Localization of the murine leukemia inhibitory factor gene near the centromere on chromosome 11

    Growth Factors

    (1990)
  • P.S. Linsley et al.

    Identification and characterization of cellular receptors for the growth regulator, oncostatin M

    J. Biol. Chem.

    (1989)
  • J. Liu et al.

    Interleukin-6 signal transducer gp130 mediates oncostatin M binding

    J. Biol. Chem.

    (1992)
  • K.A. Lord et al.

    Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation

    Mol. Cell. Biol.

    (1991)
  • D.G. Lowe et al.

    Genomic cloning and heterologous expression of human differentiation-stimulating factor

    DNA

    (1989)
  • D. Metcalf

    Suppression of myeloid leukemic cells by normal hematopoietic regulators.

  • D. Metcalf et al.

    Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro.

    Blood

    (1991)
  • S.A. Miles et al.

    Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells

    Science

    (1992)
  • J.F. Moreau et al.

    Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells

    Nature (London)

    (1988)
  • M. Murphy et al.

    Generation of sensory neurons is stimulated by leukemia inhibitory factor

    Proc. Natl. Acad. Sci. U.S.A.

    (1991)
  • A. Abdollahi et al.

    Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin-6 and leukemia inhibitory factor: Role in growth inhibition

    Cell Growth Differ.

    (1991)
  • E. Abe et al.

    Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption

    Proc. Natl. Acad. Sci. U.S.A.

    (1986)
  • E.H. Allan et al.

    Osteoblasts display receptors for and responses to leukemia-inhibitory factor

    J. Cell. Physiol.

    (1990)
  • J.B. Bard et al.

    LIF, the ES-cell inhibition factor, reversibly blocks nephrogenesis in cultured mouse kidney rudiments

    Development

    (1991)
  • H. Baumann et al.

    Regulation of hepatic acute phase plasma protein genes by hepatocyte-stimulating factors and other mediators of inflammation

    Mol. Biol. Med.

    (1990)
  • H. Baumann et al.

    Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor

    J. Immunol.

    (1989)
  • H. Baumann et al.

    The action of interleukin-6 and leukemia inhibitory factor in liver cells.

  • J.F. Bazan

    Structural design and molecular evolution of a cytokine receptor superfamily

    Proc. Natl. Acad. Sci. U.S.A.

    (1990)
  • H. Bhatt et al.

    Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation

    Proc. Natl. Acad. Sci. U.S.A.

    (1991)
  • K. Black et al.

    Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice

    Endocrinology

    (1991)
  • G. Blancho et al.

    HILDA/LIF is present in the urine of rejecting kidney graft recipients

    Transplant. Int.

    (1992)
  • T.J. Brown et al.

    Oncostatin M: A novel regulator of endothelial cell properties.

  • T.J. Brown et al.

    Differential effects of leukemia inhibitory factor and oncostatin M on endothelial cell physiology.

    J. Cell. Biochem. (Supp.)

    (1991)
  • T.J. Brown et al.

    Regulation of interleukin-6 expression by oncostatin M

    J. Immunol.

    (1991)
  • E. Bruno et al.

    Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells

    Exp. Hematol.

    (1991)
  • M. Budarf et al.

    Human differentiation stimulating factor (leukemia inhibitory, human interleukin DA) gene maps distal to the Ewing's sarcoma breakpoint on 22q

    Leukemia

    (1989)
  • M.R. Capecchi

    Altering the genome by homologous recombination

    Science

    (1989)
  • F. Conquet et al.

    Developmental expression of myeloid leukemia inhibitory factor gene in preimplantation blastocysts and in extraembryonic tissue of mouse embryos

    Mol. Cell. Biol

    (1990)
  • S. Cory et al.

    Murine erythroid cell lines derived with mye retroviruses respond to leukemia inhibitory factor, erythropoietin and interleukin-3

    Cell Growth Differ.

    (1991)
  • D. Cosman et al.

    A new cytokine receptor superfamily

    Trends Biochem. Sci.

    (1990)
  • Cited by (0)

    View full text